Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
G

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellular Therapies in 2023

By Indy Hematology Review FEATURING Gilles Salles
By Indy Hematology Review FEATURING Gilles Salles
154 views
April 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
2023
19:34

2023 Management of Long-Term Survivors of Hematologic Malignancies

Indy Hematology Review

S. Garofalo

66 views
26:05

Understanding and Managing Immune Effector Cell Toxicities in Hemato…

Indy Hematology Review

D. Reeves

76 views
73:56

Indy Hematology Review 2023: Expert Case Discussions

Indy Hematology Review

M. Wiemann, S. Usmani, J. Mikhael, M. Lunning, S. Treon, T. Phillips, J. Woyach

83 views
21:29

Indy Hematology Review 2023: Emerging Therapies in Hematologic Malig…

Indy Hematology Review

R. Birhiray

71 views
24:53

Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macr…

Indy Hematology Review

M. Gertz

209 views
26:02

Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…

Indy Hematology Review

K. Orbaugh

34 views
31:33

Sickle Cell Disease and Clotting Disorders of the Blood in 2023

Indy Hematology Review

C. Kessler

103 views
31:51

Managing Newly Diagnosed MM in 2023

Indy Hematology Review

S. Usmani

250 views
22:30

Targets and Treatments of MPNs in 2023

Indy Hematology Review

R. Mesa

332 views
32:06

Current and Emerging Therapies for AML and MDS

Indy Hematology Review

R. Larson

81 views
24:33

Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…

Indy Hematology Review

J. Woyach

1.2K views
31:25

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Indy Hematology Review

M. Lunning

75 views
34:28

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Indy Hematology Review

T. Phillips

135 views
19:42

Beyond Hyperviscosity: 80 Years and Counting - Treatment of Waldenst…

Indy Hematology Review

S. Treon

33 views
18:27

DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…

Indy Hematology Review

J. Mikhael

545 views
15:53

DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remissi…

Indy Hematology Review

S. Usmani

335 views
06:33

Indy Hematology Review 2023: Take Home Messages for MDS & AML

Indy Hematology Review

R. Komrokji

99 views
06:36

Indy Hematology Review 2023: Recent Important Results for Adult ALL

Indy Hematology Review

C. Schiffer

71 views
04:15

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

714 views
28:07

Controversies and Recommendations for the Treatment of ALL and Lymph…

Indy Hematology Review

W. Stock

634 views
38:55

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Indy Hematology Review

G. Salles

154 views
24:21

Emerging Therapies for R/R CLL

Indy Hematology Review

W. Wierda

97 views
31:43

Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…

Indy Hematology Review

A. Tefferi

776 views
24:37

Recent Updates on the Treatment of Polycythemia Vera

Indy Hematology Review

A. Fleischman

375 views
16:23

Updates on the Treatment of Myelofibrosis and FGFR-Mutated Myeloid N…

Indy Hematology Review

A. Fleischman

224 views
32:03

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

652 views
31:16

Hematopoietic Stem Cell Transplantation: State of the Art in 2023

Indy Hematology Review

R. Childs

85 views
28:25

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Indy Hematology Review

C. Kessler

1.1K views
28:41

Improving Outcomes With Current Therapies in AML and Acute Promyeloc…

Indy Hematology Review

M. Tallman

66 views
27:52

The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS

Indy Hematology Review

R. Stone

298 views
27:16

Resistant or Recurrent CML and Prospective Discontinuation

Indy Hematology Review

R. Larson

59 views